tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Ownership - Who Owns Immunovant?

Compare
919 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 19, 2025
xxxxxxxxxxxxx
$290943
Dec 12, 2025
xxxxxxxxxxxxx
$349999986
Nov 21, 2025
xxxxxxxxxxxxx
$298237
Oct 24, 2025
xxxxxxxxxxxxx
$47956

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$243718
Sep 30, 2025
xxxxxxxxxxxxx
$25596786

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
113,317,007Insider56.24%3,057,292,849
7,521,007Institution3.73%202,916,769
6,270,437Institution3.11%169,176,390
5,559,895Institution2.76%150,005,967
5,457,881Institution2.71%147,253,629
3,382,922Institution1.68%91,271,236
1,804,167Institution0.90%48,676,426
1,630,101Institution0.81%43,980,125
1,587,890Institution0.79%42,841,272
1,498,725Institution0.74%40,435,601

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,521,007Institution3.73%202,916,769
5,559,895Institution2.76%150,005,967
1,804,167Institution0.90%48,676,426
1,387,586Institution0.69%37,437,070
1,159,050Institution0.58%31,271,169
925,948Institution0.46%24,982,077
879,597Institution0.44%23,731,527
752,842Institution0.37%20,311,677
651,041Institution0.32%17,565,086
564,699Institution0.28%15,235,579

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,189,914Institution1.09%52,886,423
1,797,492Institution0.89%48,496,334
1,638,853Institution0.81%39,578,300
1,544,702Institution0.77%41,104,520
1,055,730Institution0.52%25,495,880
712,922Institution0.35%17,217,066
609,613Institution0.30%16,447,359
512,952Institution0.25%13,839,445
336,414Institution0.17%8,124,398
322,665Institution0.16%8,586,116

FAQ

Who Owns Immunovant (IMVT)?
Currently, no data Available
What percentage of Immunovant (IMVT) stock is held by institutional investors?
Currently, no data Available
What percentage of Immunovant (IMVT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Immunovant (IMVT)?
Roivant Sciences Ltd. owns the most shares of Immunovant (IMVT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.